Ectopic Pregnancies Clinical Trial
Official title:
Adnexal Mass After Methotrexate Treatment for Ectopic Pregnancies
Ectopic pregnancies are a common morbidity in the gynaecological field. Previous work done
by our team has shown the benefits of conservative treatment with only BHCG (Beta-Human
Chorionic Gonadotropin) monitoring, proving that a vast number of patients will have a self
resolution without the need for any further medical intervention. In addition, our working
hypothesis is that this process in contrast to Methotrexate is a more physiologic one with
less inflammatory and necrosis reaction.
OBJECTIVE To measure and compare the size of the ectopic mass and monitor BHCG levels of
women treated with Methotrexate and those that had a self resolution process of their
ectopic pregnancy.
Investigators aim to prove that the mass will have an enlargement trend after Methotrexate
in contrast to being stable or decrease in size with conservative treatment.
Ectopic pregnancies are a common morbidity in the gynaecological field. Previous work done
by our team has shown the benefits of conservative treatment with only BHCG (Beta-Human
Chorionic Gonadotropin) monitoring, proving that a vast number of patients will have a self
resolution without the need for any further medical intervention. In addition, our working
hypothesis is that this process in contrast to Methotrexate is a more physiologic one with
less inflammatory and necrosis reaction.
OBJECTIVE To measure and compare the size of the ectopic mass and monitor BHCG levels of
women treated with Methotrexate and those that had a self resolution process of their
ectopic pregnancy.
Investigators aim to prove that the mass will have an enlargement trend after Methotrexate
in contrast to being stable or decrease in size with conservative treatment.
PATIENTS & METHODS Patients that will be offered to join the study are those that will be
with either treated by a Methotrexate injection or those that had signs of self resolution
with our "Watchful waiting" protocol.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01589016 -
Activin A and Inhibin A in Predicting Outcome of Pregnancies of Unknown Location After Assisted Reproductive Technology
|
N/A |